Arcus Retained Earnings from 2010 to 2024

RCUS Stock

USD 17.33 0.53 3.15%

Arcus Biosciences Retained Earnings yearly trend continues to be comparatively stable with very little volatility. Retained Earnings are likely to outpace its year average in 2024. Retained Earnings is the cumulative amount of net income that Arcus Biosciences retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals

Retained Earnings

First Reported

2016-12-31

Previous Quarter

-853 M

Current Value

-946 M

Quarterly Volatility

265.7 M

Covid

Check Arcus Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcus Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 41 M, Interest Income of 43 M or Depreciation And Amortization of 16.8 M, as well as many indicators such as Price To Sales Ratio of 11.48, Dividend Yield of 0.0 or PTB Ratio of 3.39. Arcus financial statements analysis is a perfect complement when working with Arcus Biosciences Valuation or Volatility modules.

Check out the analysis of Arcus Biosciences Correlation against competitors.

For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

Latest Arcus Biosciences' Retained Earnings Growth Pattern

Below is the plot of the Retained Earnings of Arcus Biosciences over the last few years. It is the cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. Arcus Biosciences' Retained Earnings historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcus Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (849 M)

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Retained Earnings

Timeline

Arcus Retained Earnings Regression Statistics

	Arithmetic Mean	(222,902,667)
	Coefficient Of Variation	(129.62)
	Mean Deviation	224,876,622
	Median	(73,234,000)
	Standard Deviation	288,936,462
	Sample Variance	83484.3T
	Range	828.8M
	R-Value	(0.86)
	Mean Square Error	23860.5T
	R-Squared	0.73
	Significance	0.000045
	Slope	(55,375,150)
	Total Sum of Squares	1168779.9T

Arcus Retained Earnings History

	2024	-806.5 M
	2023	-849 M
	2022	-542 M
	2021	-275.4 M
	2020	-328.2 M
	2019	-205.3 M
	2018	-122.8 M

Other Fundumenentals of Arcus Biosciences

Retained Earnings Total Equity

Arcus Biosciences Retained Earnings component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Capital Surpluse	Total Liab	Long Term Investments	Total Current Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Short Term Debt	Capital Stock
Total Assets		0.99	0.93	-0.21	-0.73	0.85	0.67	0.86	0.9	0.99	0.95	0.93	0.59	0.66	0.98	-0.03	0.98	0.99	0.71	0.59
Total Stockholder Equity	0.99		0.92	-0.23	-0.67	0.81	0.7	0.83	0.88	0.95	0.91	0.91	0.5	0.57	0.96	0.03	1.0	0.99	0.78	0.5
Net Tangible Assets	0.93	0.92		-0.37	-0.88	0.83	0.53	0.86	0.99	0.92	0.85	0.9	0.72	0.77	0.94	0.09	0.92	0.93	0.69	0.71
Net Debt	-0.21	-0.23	-0.37		0.58	-0.58	0.39	-0.56	-0.45	-0.2	0.05	-0.48	-0.47	-0.45	-0.38	0.14	-0.21	-0.21	-0.03	-0.47
Retained Earnings	-0.73	-0.67	-0.88	0.58		-0.82	-0.13	-0.83	-0.93	-0.76	-0.63	-0.82	-0.92	-0.94	-0.79	-0.01	-0.66	-0.69	-0.32	-0.92
Accounts Payable	0.85	0.81	0.83	-0.58	-0.82		0.2	0.98	0.86	0.86	0.7	0.97	0.74	0.75	0.92	-0.14	0.81	0.83	0.38	0.74
Net Receivables	0.67	0.7	0.53	0.39	-0.13	0.2		0.21	0.42	0.62	0.76	0.35	-0.05	0.06	0.55	-0.02	0.71	0.7	0.87	-0.05
Short Term Investments	0.86	0.83	0.86	-0.56	-0.83	0.98	0.21		0.89	0.87	0.71	0.99	0.74	0.76	0.92	0.03	0.82	0.83	0.38	0.74
Capital Surpluse	0.9	0.88	0.99	-0.45	-0.93	0.86	0.42	0.89		0.9	0.8	0.91	0.78	0.83	0.93	0.09	0.88	0.89	0.6	0.78
Total Liab	0.99	0.95	0.92	-0.2	-0.76	0.86	0.62	0.87	0.9		0.96	0.92	0.66	0.72	0.97	-0.08	0.95	0.97	0.63	0.66
Long Term Investments	0.95	0.91	0.85	0.05	-0.63	0.7	0.76	0.71	0.8	0.96		0.8	0.56	0.63	0.89	-0.08	0.92	0.93	0.66	0.56
Total Current Assets	0.93	0.91	0.9	-0.48	-0.82	0.97	0.35	0.99	0.91	0.92	0.8		0.72	0.74	0.96	-0.01	0.89	0.91	0.49	0.72
Common Stock	0.59	0.5	0.72	-0.47	-0.92	0.74	-0.05	0.74	0.78	0.66	0.56	0.72		0.99	0.65	-0.12	0.51	0.55	0.03	1.0
Property Plant Equipment	0.66	0.57	0.77	-0.45	-0.94	0.75	0.06	0.76	0.83	0.72	0.63	0.74	0.99		0.7	-0.12	0.58	0.61	0.12	0.99
Current Deferred Revenue	0.98	0.96	0.94	-0.38	-0.79	0.92	0.55	0.92	0.93	0.97	0.89	0.96	0.65	0.7		-0.11	0.96	0.97	0.67	0.65
Deferred Long Term Liab	-0.03	0.03	0.09	0.14	-0.01	-0.14	-0.02	0.03	0.09	-0.08	-0.08	-0.01	-0.12	-0.12	-0.11		-0.03	-0.06	0.05	-0.13
Net Invested Capital	0.98	1.0	0.92	-0.21	-0.66	0.81	0.71	0.82	0.88	0.95	0.92	0.89	0.51	0.58	0.96	-0.03		1.0	0.79	0.51
Net Working Capital	0.99	0.99	0.93	-0.21	-0.69	0.83	0.7	0.83	0.89	0.97	0.93	0.91	0.55	0.61	0.97	-0.06	1.0		0.76	0.55
Short Term Debt	0.71	0.78	0.69	-0.03	-0.32	0.38	0.87	0.38	0.6	0.63	0.66	0.49	0.03	0.12	0.67	0.05	0.79	0.76		0.03
Capital Stock	0.59	0.5	0.71	-0.47	-0.92	0.74	-0.05	0.74	0.78	0.66	0.56	0.72	1.0	0.99	0.65	-0.13	0.51	0.55	0.03

Click cells to compare fundamentals

About Arcus Biosciences Financial Statements

Arcus Biosciences shareholders use historical fundamental indicators, such as Retained Earnings, to determine how well the company is positioned to perform in the future. Although Arcus Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Arcus Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcus Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Retained Earnings	-849 M	-806.5 M
Retained Earnings Total Equity	-247.8 M	-260.2 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC